Health Insurance
Health Plans Must Provide Price Comparison Tool for 2023
Beginning in 2023, group health plans and health insurance issuers must make an internet-based price comparison tool available to participants, beneficiaries, and enrollees. The purpose of this tool is to provide consumers with real-time estimates of their cost-sharing liability from different providers for covered items and services, including prescription drugs, so they can shop and compare prices before receiving care.
Legalized Marijuana and Employment: Off-duty Use and Drug Testing
While all marijuana use remains illegal under federal law, most states have enacted laws that allow certain uses of marijuana or a marijuana derivative. None of these laws place any restrictions on an employer’s right to administer drug tests or to prohibit their employees from using or being under the influence of marijuana at work or during work hours. However,
DOL Issues Model Notices, FAQs for COBRA Subsidy in the ARPA
To view the links provided in the file above, please click to download.
Proposed Federal Guidelines Mandate Weekly COVID-19 Testing at Nursing Homes
Nursing homes across the United States face intense challenges from the effects of COVID-19. The fact that 42% of deaths from the virus are associated with nursing homes is alarming, especially when you consider these facilities relate to only 8% of all cases. Understaffing and litigation are becoming major problems. Proposed solutions include professional liability insurance coverage, federal funding, and
COVID-19 – Federal Laws Affecting Health Care
The Families First Coronavirus Response Act (FFCRA or Act) Effective March 18, 2020, the Families First Coronavirus Response Act (FFCRA) requires group health plans and health insurance issuers to cover COVID-19 testing without imposing any cost sharing (such as deductibles, copayments or coinsurance) or prior authorization or other medical management requirements. This coverage mandate applies to the following health plans
